Helicobacter pylori in children and adolescents

Adolescent Medicine Clinics

Volumn 15, Issue 1, 2004, Pages 53-66

  Chelimsky, Gisela ^a   Blanchard, Samra S ^a   Czinn, Steven J ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH CITRATE; BISMUTH SALICYLATE; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; TETRACYCLINE DERIVATIVE; TINIDAZOLE;

ABDOMINAL PAIN; CLINICAL TRIAL; DEVELOPED COUNTRY; DRUG EFFICACY; DRUG TOLERABILITY; ERADICATION THERAPY; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PATIENT COMPLIANCE; PEPTIC ULCER; PREVALENCE; REVIEW; SIDE EFFECT; SOCIAL STATUS; STOMACH CANCER; STOMACH LYMPHOMA;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CHILD; CHILD WELFARE; DRUG THERAPY, COMBINATION; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 3142735791     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2003.11.004     Document Type: Review

References (73)

1. Warren J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1:1983;1273
2. Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1:1983;1273-1275
3. Marshall B., Armstrong J., McGechie D., et al. Attempt to fulfill Koch's postulates for pyloric Campylobacter. Med J Aust. 142:1985;436-439
4. Marshall B., Warren J. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1:1984;1311-1315
5. Morris A., Ali M., Nicholson G., et al. Long-term follow up of voluntary ingestion of Helicobacter pylori. Ann Inten Med. 114:1991;662-663
6. Blaser M. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis. 161:1990;626-633
7. Goodwin C., Armstrong J., Chilvers T., et al. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively. Int J Syst Bacteriol. 39:1989;397-405
8. Solnick J., Schauer D. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Cli Microbiol Rev. 14:2001;59-97
9. Alm R., Ling L., Moir D., et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 397:1999;176-180
10. Tomb J.F., White O., Kerlavage A.R., et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 388:1997;539-547
11. Han S., Zschausch H., Meyer H., et al. Helicobacter pylori: clonal population structure and restricted transmission within families revealed by molecular typing. J Clin Microbiol. 38:2000;3646-3651
12. Go M. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther. 16:(Suppl 1):2002;3-15
13. Malaty H., Graham D. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut. 35:1994;742-745
14. Malaty H.M., Kumagai T., Tanaka E., et al. Evidence from a nine-year birth cohort study in Japan of transmission pathways of Helicobacter pylori infection. J Clin Microbiol. 38:2000;1971-1973
15. Tindberg Y., Bengtsson C., Granath F., et al. Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology. 121:2001;310-316
16. Parsonnet J., Shmuely H., Haggerty T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA. 282:1999;2240-2245
17. Handt L., Fox J., Stalis H. Characterization of feline Helicobacter pylori strains and associated gastritis in a colony of domestic cats. J Clin Microbiol. 33:1995;2280-2289
18. Klein P., Gpw G., Graham D., et al. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Lancet. 337:1991;1503-1506
19. Lu Y., Redlinger T.E., Avitia R., et al. Isolation and genotyping of Helicobacter pylori from untreated municipal wastewater. Appl Environ Microbiol. 68:2002;1436-1439
20. Guelrud M., Mujica C., Jaen D., et al. Prevalence of Helicobacter pylori in neonates and young infants undergoing ERCP for diagnosis of neonatal cholestasis. J Pediatr Gastroenterol Nutr. 18:1994;461-464
21. Rothenbacher D., Inceoglu J., Bode G., et al. Acquisition of Helicobacter pylori infection in a high-risk population occurs within the first 2 years of life. J Pediatr. 136:2000;744-748
22. Thomas J.E., Dale A., Harding M., et al. Helicobacter pylori colonization in early life. Pediatr Res. 45:1999;218-223
23. Thomas J., Gibson G., Darboe M., et al. Isolation of Helicobacter pylori from human feces. Lancet. 340:1992;1194-1195
24. Cover T.L., Blaser M.J. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem. 267:1992;10570-10575
25. Mahdavi J., Sonden B., Hurtig M., et al. Helicobacter pylori sabA adhesin in persistent infection and chronic inflammation. Science. 297:2002;573-578
26. Phadnis S.H., Ilver D., Janzon L., et al. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun. 62:1994;1557-1565
27. Satin B., Del Giudice G., Della Bianca V., et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med. 191:2000;1467-1476
28. Yale C., Balish E., Wu J. The bacterial etiology of pneumatosis cystoides intestinalis. Arch Surg. 109:1974;89-94
29. Atherton J.C., Cao P., Peek R.M. Jr, et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 270:1995;17771-17777
30. van Doorn L.J., Figueiredo C., Sanna R., Blaser M., et al. Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes. J Clin Microbiol. 37:1999;2306-2311
31. Weel J.F., van der Hulst R.W., Gerrits Y., et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis. 173:1996;1171-1175
32. Akopyants N.S., Clifton S.W., Kersulyte D., et al. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol. 28:1998;37-53
33. Censini S., Lange C., Xiang Z., et al. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA. 93:1996;14648-14653
34. Blaser M., Perez-Perez G., Kleanthous H., et al. Infection with Helicobacter pylori strains possessing cagA associated with risk of developing adenocarcinoma of the stomach. Cancer Res. 55:1995;2111-2115
35. Gold B.D. New approaches to Helicobacter pylori infection in children. Curr Gastroenterol Rep. 3:2001;235-247
36. Day A.S., Jones N.L., Lynett J.T., et al. CagE is a virulence factor associated with Helicobacter pylori-induced duodenal ulceration in children. J Infect Dis. 181:2000;1370-1375
37. El-Omar E.M., Carrington M., Chow W.H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 404:2000;398-402
38. Ernst P.B., Gold B.D. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol. 54:2000;615-640
39. Forman D., Webb P., Parsonnet J. H. pylori and gastric cancer. Lancet. 343:1994;243-244
40. Parsonnet J., Friedman G.D., Orentreich N., et al. Risk for gastric cancer in people with cagA positive or cagA negative Helicobacter pylori infection. Gut. 40:1997;297-301
41. Parsonnet J., Friedman G.D., Vandersteen D.P., et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 325:1991;1127-1131
42. Bayerdorffer E., Miehlke S., Neubauer A., et al. Gastric MALT-lymphoma and Helicobacter pylori infection. Aliment Pharmacol Ther. 11:(Suppl 1):1997;89-94
43. World Health Organization. Infection with Helicobacter pylori. Schistosomes, liver flukes and Helicobacter pylori. vol. 61:1994;177-241 International Agency for Research on Cancer, Lyon, France
44. Bayerdorffer E., Neubauer A., Rudolph B., et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet. 345:1995;1591-1594
45. Olson A.D., Fendrick A.M., Deutsch D., et al. Evaluation of initial noninvasive therapy in pediatric patients presenting with suspected ulcer disease. Gastrointest Endosc. 44:1996;554-561
46. Cutler A.F., Havstad S., Ma C.K., et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 109:1995;136-141
47. Kabir S. Review article: clinic-based testing for Helicobacter pylori infection by enzyme immunoassay of faeces, urine and saliva. Aliment Pharmacol Ther. 17:2003;1345-1354
48. Oderda G., Rapa A., Ronchi B., et al. Detection of Helicobacter pylori in stool specimens by non-invasive antigen enzyme immunoassay in children: multicentre Italian study. BMJ. 320:2000;347-348
49. Oderda G., Rapa A., Marinello D., et al. Usefulness of Helicobacter pylori stool antigen test to monitor response to eradication treatment in children. Aliment Pharmacol Ther. 15:2001;203-206
50. Manes G., Balzano A., Iaquinto G., et al. Accuracy of stool antigen test in posteradication assessment of Helicobacter pylori infection. Dig Dis Sci. 46:2001;2440-2444
51. Gold B., Colletti R., Abbott M., et al. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr. 31:2000;490-497
52. Gold B.D., van Doorn L.J., Guarner J., et al. Genotypic, clinical, and demographic characteristics of children infected with Helicobacter pylori. J Clin Microbiol. 39:2001;1348-1352
53. Kato S., Takeyama J., Ebina K., et al. Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children. Pediatrics. 100:1997;E3
54. Dohil R., Israel D.M., Hassall E. Effective 2-wk therapy for Helicobacter pylori disease in children. Am J Gastroenterol. 92:1997;244-247
55. Walsh D., Drumm B. Helicobacter pylori: challenges for the paediatrician. J Paediatr Child Health. 33:1997;469-470
56. Gold B.D. Current therapy for Helicobacter pylori infection in children and adolescents. Can J Gastroenterol. 13:1999;571-579
57. Azarow K., Kim P., Shandling B., et al. A 45-year experience with surgical treatment of peptic ulcer disease in children. J Pediatr Surg. 31:1996;750-753
58. Michetti P., Kreiss C., Kotloff K.L., et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology. 116:1999;804-812
59. van der Meer S., Forget P., Loffeld R., et al. The prevalence of Helicobacter pylori serum antibodies in children with recurrent abdominal pain. Eur J Pediatr. 152:1992;799-801
60. McCallon W., Bailie A., Ardill J., et al. Helicobacter pylori, hypergastrinemia, and recurrent abdominal pain in children. J Pediatr Surg. 30:1995;427-429
61. Chong S., Blackshaw A., Morson B., et al. Prospective study of colitis in infancy and early childhood. J Ped Gastroenterol Nutr. 5:1986;352-358
62. Hardikar W., Davidson P., Cameron D. Helicobacter pylori infection in children. J Gastroenterol Hepatol. 6:1991;450-454
63. O'Donohoe J.M., Sullivan P.B., Scott R., et al. Recurrent abdominal pain and Helicobacter pylori in a community-based sample of London children [see comments]. Acta Paediatr. 85:1996;961-964
64. Bode G., Rothenbacher D., Brenner H., et al. Variation in the 13C-urea breath test value by nationality in Helicobacter pylori-infected children. Scand J Gastroenterol. 33:1998;468-472
65. Tiren U., Sandstedt B., Finkel Y. Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole. Acta Paediatr. 88:1999;166-168
66. Walsh D., Goggin N., Rowland M., et al. One week treatment for Helicobacter pylori infection. Arch Dis Child. 76:1997;352-355
67. Urruzuno P., Cilleuruelo M., Martinez M., et al. Randomized study comaring two seven days triple therapy for Helicobacter pylori eradication in children. Gut. 43:1998;A71
68. Shashidhar H., Peters J., Lin C.H., et al. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 30:2000;276-282
69. Gottrand F., Kalach N., Spyckerelle C., et al. Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: a prospective randomized double-blind trial. J Pediatr. 139:2001;664-668
70. Kocak N., Saltik I.N., Ozen H., et al. Lansoprazole triple therapy for Turkish children with Helicobacter pylori infections. J Pediatr Gastroenterol Nutr. 32:2001;614
71. Casswall T.H., Alfven G., Drapinski M., et al. One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 27:1998;415-418
72. Nijevitch A.A., Farztdinov K.M., Sataev V.U., et al. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole. J Gastroenterol Hepatol. 15:2000;1243-1250
73. Moshkowitz M., Reif S., Brill S., et al. One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents. Pediatrics. 102:(14):1998;135